Eli Lilly (LLY) Revenue Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
55.54% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
9.91% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
12.43% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
4.87% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
5.76% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
4.39% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
10.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
2.57% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
55.54% |
| Dec 31, 2025 |
42.55% |
| Sep 30, 2025 |
53.87% |
| Jun 30, 2025 |
37.64% |
| Mar 31, 2025 |
45.18% |
| Dec 31, 2024 |
44.69% |
| Sep 30, 2024 |
20.43% |
| Jun 30, 2024 |
35.98% |
| Mar 31, 2024 |
25.98% |
| Dec 31, 2023 |
28.10% |
| Sep 30, 2023 |
36.84% |
| Jun 30, 2023 |
28.11% |
| Mar 31, 2023 |
-10.88% |
| Dec 31, 2022 |
-8.73% |
| Sep 30, 2022 |
2.49% |
| Jun 30, 2022 |
-3.74% |
| Mar 31, 2022 |
14.76% |
| Dec 31, 2021 |
7.53% |
| Sep 30, 2021 |
17.98% |
| Jun 30, 2021 |
22.56% |
| Mar 31, 2021 |
16.14% |
| Dec 31, 2020 |
21.69% |
| Sep 30, 2020 |
4.82% |
| Jun 30, 2020 |
-2.44% |
| Mar 31, 2020 |
15.07% |
| Dec 31, 2019 |
8.45% |
| Sep 30, 2019 |
3.20% |
| Jun 30, 2019 |
0.93% |
| Mar 31, 2019 |
2.59% |
| Dec 31, 2018 |
-8.49% |
| Sep 30, 2018 |
-6.21% |
| Jun 30, 2018 |
-4.11% |
| Mar 31, 2018 |
-5.06% |
| Dec 31, 2017 |
6.95% |
| Sep 30, 2017 |
8.98% |
| Jun 30, 2017 |
7.76% |
| Mar 31, 2017 |
7.47% |
| Dec 31, 2016 |
7.16% |
| Sep 30, 2016 |
4.68% |
| Jun 30, 2016 |
8.56% |
| Mar 31, 2016 |
4.75% |
| Dec 31, 2015 |
4.97% |
| Sep 30, 2015 |
1.72% |
| Jun 30, 2015 |
0.87% |
| Mar 31, 2015 |
-0.82% |
| Dec 31, 2014 |
-11.84% |
| Sep 30, 2014 |
-15.54% |
| Jun 30, 2014 |
-16.76% |
| Mar 31, 2014 |
-16.40% |
| Dec 31, 2013 |
-2.49% |
| Sep 30, 2013 |
6.05% |
| Jun 30, 2013 |
5.87% |
| Mar 31, 2013 |
0.00% |
| Dec 31, 2012 |
-1.48% |
| Sep 30, 2012 |
-11.46% |
| Jun 30, 2012 |
-10.43% |
| Mar 31, 2012 |
-4.06% |
| Dec 31, 2011 |
-2.27% |
| Sep 30, 2011 |
12.05% |
| Jun 30, 2011 |
11.87% |
| Mar 31, 2011 |
6.45% |
| Dec 31, 2010 |
4.26% |
| Sep 30, 2010 |
1.88% |
| Jun 30, 2010 |
5.60% |
| Mar 31, 2010 |
8.69% |
